Metrics is a full-service global contract development and manufacturing organization (CDMO) specializing in oral and topical dosage forms. A subsidiary of Mayne Pharma Group Limited, Metrics also offers clients an impressive portfolio of advanced proprietary delivery methods for controlled release, bioavailability enhancement and taste masking.
Founded as a contract analytical laboratory in 1994, Metrics has evolved into a provider of:
Greenville, NC-based Metrics offers particular expertise in First-Time-In-Man (FTIM) and Phase I, II, and III Clinical Trial Manufacturing (CTM) – conducting more than 130 FTIM projects for different chemical entities while concurrently developing more than 700 CTM batches.
Globally, Metrics provides a broad spectrum of contract services to support investigational new drug (IND), new drug (NDA) and abbreviated new drug (ANDA) submissions to regulatory agencies.
Our technical capabilities include highly potent, cytotoxic and unstable compounds; Schedule II-V controlled substances; and products with poor bioequivalence.